{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:00:37Z","timestamp":1790532037353,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["G-252-249-38"],"award-info":[{"award-number":["G-252-249-38"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00210-018-1577-2","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T02:27:18Z","timestamp":1544149638000},"page":"381-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["2-Methoxyestradiol attenuates liver fibrosis in mice: implications for M2 macrophages"],"prefix":"10.1007","volume":"392","author":[{"given":"Thikryat","family":"Neamatallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf B.","family":"Abdel-Naim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma G.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"1577_CR1","doi-asserted-by":"crossref","first-page":"4389484","DOI":"10.1155\/2018\/4389484","volume":"2018","author":"AB Abdel-Naim","year":"2018","unstructured":"Abdel-Naim AB, Neamatallah T, Eid BG, Esmat A, Alamoudi AJ, Abd El-Aziz GS, Ashour OM (2018) 2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1\u03b1\/TGF-\u03b2\/Smad2 Axis. Oxidative Med Cell Longev 2018:4389484","journal-title":"Oxidative Med Cell Longev"},{"key":"1577_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3892\/or.2015.4399","volume":"35","author":"A Aquino-Galvez","year":"2016","unstructured":"Aquino-Galvez A, Gonzalez-Avila G, Delgado-Tello J, Castillejos-Lopez M, Mendoza-Milla C, Zuniga J, Checa M, Maldonado-Martinez HA, Trinidad-Lopez A, Cisneros J, Torres-Espindola LM, Hernandez-Jimenez C, Sommer B, Cabello-Gutierrez C, Gutierrez-Gonzalez LH (2016) Effects of 2-methoxyestradiol on apoptosis and HIF-1alpha and HIF-2alpha expression in lung cancer cells under normoxia and hypoxia. Oncol Rep 35:577\u2013583","journal-title":"Oncol Rep"},{"key":"1577_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209\u2013218","journal-title":"J Clin Invest"},{"key":"1577_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2353\/ajpath.2008.061244","volume":"172","author":"CM Becker","year":"2008","unstructured":"Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A, Folkman J, D\u2019amato RJ (2008) 2-Methoxyestradiol inhibits hypoxia-inducible factor-1\u03b1 and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol 172:534\u2013544","journal-title":"Am J Pathol"},{"key":"1577_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fimmu.2014.00430","volume":"5","author":"L Beljaars","year":"2014","unstructured":"Beljaars L, Schippers M, Reker-Smit C, Martinez FO, Helming L, Poelstra K, Melgert BN (2014) Hepatic localization of macrophage phenotypes during fibrogenesis and resolution of fibrosis in mice and humans. Front Immunol 5:430","journal-title":"Front Immunol"},{"key":"1577_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02718274","volume":"251","author":"FD Berg","year":"1992","unstructured":"Berg FD, Kuss E (1992) Serum concentration and urinary excretion of \u201cclassical\u201d estrogens, catecholestrogens and 2-methoxyestrogens in normal human pregnancy. Arch Gynecol Obstet 251:17\u201327","journal-title":"Arch Gynecol Obstet"},{"key":"1577_CR7","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s10637-010-9618-9","volume":"30","author":"JY Bruce","year":"2012","unstructured":"Bruce JY, Eickhoff J, Pili R, Logan T, Carducci M, Arnott J, Treston A, Wilding G, Liu G (2012) A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate. Investig New Drugs 30:794\u2013802","journal-title":"Investig New Drugs"},{"key":"1577_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/hep.20611","volume":"41","author":"M Campbell","year":"2005","unstructured":"Campbell M, Yang YX, Reddy KR (2005) Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 41:939 author reply 939-40","journal-title":"Hepatology"},{"key":"1577_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/hep.20051","volume":"39","author":"A Canbay","year":"2004","unstructured":"Canbay A, Friedman S, Gores GJ (2004) Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39:273\u2013278","journal-title":"Hepatology"},{"key":"1577_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/157016211797635982","volume":"9","author":"J Collazos","year":"2011","unstructured":"Collazos J, Carton JA, Asensi V (2011) Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus. Curr HIV Res 9:339\u2013345","journal-title":"Curr HIV Res"},{"key":"1577_CR11","doi-asserted-by":"publisher","unstructured":"Dahut WL, Lakhani NJ, Gulley JL, Arlen PM, Kohn EC, Kotz H, McNally D, Parr A, Parr A, Nguyen D, Yang SX, Steinberg SM, Venitz J, Sparreboom A, Figg II W (2014) Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biology & Therapy 5(1):22\u201327. https:\/\/doi.org\/10.4161\/cbt.5.1.2349","DOI":"10.4161\/cbt.5.1.2349"},{"key":"1577_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbrc.2014.10.076","volume":"454","author":"J Deng","year":"2014","unstructured":"Deng J, Huang Q, Wang Y, Shen P, Guan F, Li J, Huang H, Shi C (2014) Hypoxia-inducible factor-1alpha regulates autophagy to activate hepatic stellate cells. Biochem Biophys Res Commun 454:328\u2013334","journal-title":"Biochem Biophys Res Commun"},{"key":"1577_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1046\/j.1365-2893.2002.00340.x","volume":"9","author":"S Deuffic-Burban","year":"2002","unstructured":"Deuffic-Burban S, Poynard T, Valleron AJ (2002) Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model. J Viral Hepat 9:114\u2013122","journal-title":"J Viral Hepat"},{"key":"1577_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.tem.2009.04.007","volume":"20","author":"RK Dubey","year":"2009","unstructured":"Dubey RK, Jackson EK (2009) Potential vascular actions of 2-methoxyestradiol. Trends Endocrinol Metab 20:374\u2013379","journal-title":"Trends Endocrinol Metab"},{"key":"1577_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/bbrc.2000.3755","volume":"278","author":"RK Dubey","year":"2000","unstructured":"Dubey RK, Gillespie DG, Zacharia LC, Rosselli M, Korzekwa KR, Fingerle J, Jackson EK (2000) Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. Biochem Biophys Res Commun 278:27\u201333","journal-title":"Biochem Biophys Res Commun"},{"key":"1577_CR16","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655\u20131669","journal-title":"Gastroenterology"},{"key":"1577_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23\u201335","journal-title":"Nat Rev Immunol"},{"key":"1577_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593\u2013604","journal-title":"Immunity"},{"key":"1577_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10637-010-9455-x","volume":"29","author":"MR Harrison","year":"2011","unstructured":"Harrison MR, Hahn NM, Pili R, Oh WK, Hammers H, Sweeney C, Kim K, Perlman S, Arnott J, Sidor C, Wilding G, Liu G (2011) A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal\u00ae dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Invest New Drugs 29:1465\u20131474","journal-title":"Invest New Drugs"},{"key":"1577_CR20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.24764","volume":"55","author":"F Heymann","year":"2012","unstructured":"Heymann F, Hammerich L, Storch D, Bartneck M, Huss S, R\u00fcsseler V, Gassler N, Lira SA, Luedde T, Trautwein C, Tacke F (2012) Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology (Baltimore, Md.) 55:898\u2013909","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"1577_CR21","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1126\/science.1204351","volume":"332","author":"SJ Jenkins","year":"2011","unstructured":"Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, Van Rooijen N, Macdonald AS, Allen JE (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of Th2 inflammation. Science (New York, NY) 332:1284\u20131288","journal-title":"Science (New York, NY)"},{"key":"1577_CR22","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1084\/jem.20121999","volume":"210","author":"SJ Jenkins","year":"2013","unstructured":"Jenkins SJ, Ruckerl D, Thomas GD, Hewitson JP, Duncan S, Brombacher F, Maizels RM, Hume DA, Allen JE (2013) IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J Exp Med 210:2477\u20132491","journal-title":"J Exp Med"},{"key":"1577_CR23","doi-asserted-by":"publisher","unstructured":"Kang S-H, Cho HT, Devi S, Zhang Z, Escuin D, Liang Z, Mao H, Brat DJ, Olson JJ, Simons JW, LaVallee TM, Giannakakou P, Van Meir EG, Shim H (2006) Antitumor effect of 2-Methoxyestradiol in a rat orthotopic brain tumor model. Cancer Res 66(24):11991\u201311997. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1320","DOI":"10.1158\/0008-5472.CAN-06-1320"},{"key":"1577_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1592\/phco.23.2.165.32088","volume":"23","author":"NJ Lakhani","year":"2003","unstructured":"Lakhani NJ, Sarkar MA, Venitz J, Figg WD (2003) 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23:165\u2013172","journal-title":"Pharmacotherapy"},{"key":"1577_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1755-1536-6-19","volume":"6","author":"C Liedtke","year":"2013","unstructured":"Liedtke C, Luedde T, Sauerbruch T, Scholten D, Streetz K, Tacke F, Tolba R, Trautwein C, Trebicka J, Weiskirchen R (2013) Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair 6:19","journal-title":"Fibrogenesis Tissue Repair"},{"key":"1577_CR26","doi-asserted-by":"publisher","first-page":"G471","DOI":"10.1152\/ajpgi.2000.279.3.G471","volume":"279","author":"JN Lindquist","year":"2000","unstructured":"Lindquist JN, Marzluff WF, Stefanovic B (2000) Fibrogenesis. III. Posttranscriptional regulation of type I collagen. Am J Physiol Gastrointest Liver Physiol 279:G471\u2013G476","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1577_CR27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3748\/wjg.v10.i9.1315","volume":"10","author":"QH Liu","year":"2004","unstructured":"Liu QH, Li DG, Huang X, Zong CH, Xu QF, Lu HM (2004) Suppressive effects of 17beta-estradiol on hepatic fibrosis in CCl4-induced rat model. World J Gastroenterol 10:1315\u20131320","journal-title":"World J Gastroenterol"},{"key":"1577_CR28","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Navarrete G, Ramos-Mart\u00ednez E, Su\u00e1rez-\u00c1lvarez K, Aguirre-Garc\u00eda J, Ledezma-Soto Y, Le\u00f3n-Cabrera S, Gudi\u00f1o-Zayas M, Guzm\u00e1n C, Guti\u00e9rrez-Reyes G, Hern\u00e1ndez-Ru\u00edz J, Camacho-Arroyo I, Robles-D\u00edaz G, Kershenobich D, Terrazas LI, Escobedo G (2011) Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation. Int J Biol Sci 7:1273\u20131286. https:\/\/doi.org\/10.7150\/ijbs.7.1273","DOI":"10.7150\/ijbs.7.1273"},{"key":"1577_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gut.50.6.891","volume":"50","author":"DA Mann","year":"2002","unstructured":"Mann DA, Smart DE (2002) Transcriptional regulation of hepatic stellate cell activation. Gut 50:891\u2013896","journal-title":"Gut"},{"key":"1577_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677\u2013686","journal-title":"Trends Immunol"},{"key":"1577_CR31","doi-asserted-by":"publisher","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","volume":"302","author":"K Miura","year":"2012","unstructured":"Miura K, Yang L, Van Rooijen N, Ohnishi H, Seki E (2012) Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol 302:G1310\u2013G1321","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1577_CR32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958\u2013969","journal-title":"Nat Rev Immunol"},{"key":"1577_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.steroids.2010.02.016","volume":"75","author":"AO Mueck","year":"2010","unstructured":"Mueck AO, Seeger H (2010) 2-Methoxyestradiol--biology and mechanism of action. Steroids 75:625\u2013631","journal-title":"Steroids"},{"key":"1577_CR34","doi-asserted-by":"publisher","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7(2):27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703","DOI":"10.4103\/0976-0105.177703"},{"key":"1577_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1128\/IAI.73.1.385-394.2005","volume":"73","author":"MG Nair","year":"2005","unstructured":"Nair MG, Gallagher IJ, Taylor MD, Loke P, Coulson PS, Wilson RA, Maizels RM, Allen JE (2005) Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 73:385\u2013394","journal-title":"Infect Immun"},{"key":"1577_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00795-003-0228-x","volume":"37","author":"M Naito","year":"2004","unstructured":"Naito M, Hasegawa G, Ebe Y, Yamamoto T (2004) Differentiation and function of Kupffer cells. Med Electron Microsc 37:16\u201328","journal-title":"Med Electron Microsc"},{"key":"1577_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2174\/1389557515666150226121052","volume":"15","author":"A Parada-Bustamante","year":"2015","unstructured":"Parada-Bustamante A, Valencia C, Reuquen P, Diaz P, Rincion-Rodriguez R, Orihuela PA (2015) Role of 2-methoxyestradiol, an endogenous estrogen metabolite, in health and disease. Mini Rev Med Chem 15:427\u2013438","journal-title":"Mini Rev Med Chem"},{"key":"1577_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA (2014) Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 14:181\u2013194","journal-title":"Nat Rev Immunol"},{"key":"1577_CR39","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1053\/j.gastro.2011.01.040","volume":"140","author":"Y Popov","year":"2011","unstructured":"Popov Y, Sverdlov DY, Sharma AK, Bhaskar KR, Li S, Freitag TL, Lee J, Dieterich W, Melino G, Schuppan D (2011) Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice. Gastroenterology 140:1642\u20131652","journal-title":"Gastroenterology"},{"key":"1577_CR40","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","volume":"34","author":"T Poynard","year":"2001","unstructured":"Poynard T, Ratziu V, Charlotte F, Goodman Z, Mchutchison J, Albrecht J (2001) Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol 34:730\u2013739","journal-title":"J Hepatol"},{"key":"1577_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0168-8278(02)00413-0","volume":"38","author":"T Poynard","year":"2003","unstructured":"Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P, GROUP, P (2003) A comparison of fibrosis progression in chronic liver diseases. J Hepatol 38:257\u2013265","journal-title":"J Hepatol"},{"key":"1577_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1023\/A:1026543018478","volume":"19","author":"VS Pribluda","year":"2000","unstructured":"Pribluda VS, Gubish ER Jr, Lavallee TM, Treston A, Swartz GM, Green SJ (2000) 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 19:173\u2013179","journal-title":"Cancer Metastasis Rev"},{"key":"1577_CR43","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL (2013) Hepatic stellate cells and liver fibrosis. Compr Physiol 3:1473\u20131492","journal-title":"Compr Physiol"},{"key":"1577_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/1044667031000137629","volume":"9","author":"G Raes","year":"2002","unstructured":"Raes G, Noel W, Beschin A, Brys L, De Baetselier P, Hassanzadeh GH (2002) FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev Immunol 9:151\u2013159","journal-title":"Dev Immunol"},{"key":"1577_CR45","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.4049\/jimmunol.174.11.6561","volume":"174","author":"G Raes","year":"2005","unstructured":"Raes G, van den Bergh R, de Baetselier P, Ghassabeh GH (2005) Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J Immunol 174:6561\u20136562","journal-title":"J Immunol"},{"key":"1577_CR46","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, Hartland SN, Snowdon VK, Cappon A, Gordon-Walker TT, Williams MJ, Dunbar DR, Manning JR, Van Rooijen N, Fallowfield JA, Forbes SJ, Iredale JP (2012) Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A 109:E3186\u2013E3195","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1577_CR47","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.1158\/1078-0432.CCR-04-1393","volume":"10","author":"JL Ricker","year":"2004","unstructured":"Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, van Waes C (2004) 2-Methoxyestradiol inhibits hypoxia-inducible factor 1\u03b1, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Clin Cancer Res 10:8665\u20138673","journal-title":"Clin Cancer Res"},{"key":"1577_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/labinvest.3700704","volume":"88","author":"KA Rygiel","year":"2008","unstructured":"Rygiel KA, Robertson H, Marshall HL, Pekalski M, Zhao L, Booth TA, Jones DE, Burt AD, Kirby JA (2008) Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Investig 88:112\u2013123","journal-title":"Lab Investig"},{"key":"1577_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1247\/csf.28.105","volume":"28","author":"M Sato","year":"2003","unstructured":"Sato M, Suzuki S, Senoo H (2003) Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct 28:105\u2013112","journal-title":"Cell Struct Funct"},{"key":"1577_CR50","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jhbp.245","volume":"22","author":"E Seki","year":"2015","unstructured":"Seki E, Brenner DA (2015) Recent advancement of molecular mechanisms of liver fibrosis. J Hepato-Biliary Pancreat Sci 22:512\u2013518","journal-title":"J Hepato-Biliary Pancreat Sci"},{"key":"1577_CR51","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke F, Zimmermann HW (2014) Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 60:1090\u20131096","journal-title":"J Hepatol"},{"key":"1577_CR52","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-08-1599","volume":"15","author":"AJ Tevaarwerk","year":"2009","unstructured":"Tevaarwerk AJ, Holen KD, Alberti DB, Sidor C, Arnott J, Quon C, Wilding G, Liu G (2009) Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies. Clin Cancer Res 15:1460\u20131465","journal-title":"Clin Cancer Res"},{"key":"1577_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.vph.2009.06.002","volume":"51","author":"SP Tofovic","year":"2009","unstructured":"Tofovic SP, Zhang X, Jackson EK, Zhu H, Petrusevska G (2009) 2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats. Vasc Pharmacol 51:190\u2013197","journal-title":"Vasc Pharmacol"},{"key":"1577_CR54","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1158\/1078-0432.CCR-05-2172","volume":"12","author":"V Vijayanathan","year":"2006","unstructured":"Vijayanathan V, Venkiteswaran S, Nair SK, Verma A, Thomas TJ, Zhu BT, Thomas T (2006) Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17\u03b2-estradiol in human breast cancer cells. Clin Cancer Res 12:2038\u20132048","journal-title":"Clin Cancer Res"},{"key":"1577_CR55","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.3892\/etm.2017.4243","volume":"13","author":"L Wang","year":"2017","unstructured":"Wang L, Zheng Q, Yuan Y, Li Y, Gong X (2017) Effects of 17beta-estradiol and 2-methoxyestradiol on the oxidative stress-hypoxia inducible factor-1 pathway in hypoxic pulmonary hypertensive rats. Exp Ther Med 13:2537\u20132543","journal-title":"Exp Ther Med"},{"key":"1577_CR56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214:199\u2013210","journal-title":"J Pathol"},{"key":"1577_CR57","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","volume":"30","author":"TA Wynn","year":"2010","unstructured":"Wynn TA, Barron L (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30:245\u2013257","journal-title":"Semin Liver Dis"},{"key":"1577_CR58","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn TA, Vannella KM (2016) Macrophages in tissue repair, regeneration, and Fibrosis. Immunity 44:450\u2013462","journal-title":"Immunity"},{"key":"1577_CR59","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3748\/wjg.v8.i5.883","volume":"8","author":"JW Xu","year":"2002","unstructured":"Xu JW, Gong J, Chang XM, Luo JY, Dong L, Hao ZM, Jia A, Xu GP (2002) Estrogen reduces CCL4-induced liver fibrosis in rats. World J Gastroenterol 8:883\u2013887","journal-title":"World J Gastroenterol"},{"key":"1577_CR60","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3748\/wjg.v10.i2.250","volume":"10","author":"JW Xu","year":"2004","unstructured":"Xu JW, Gong J, Chang XM, Luo JY, Dong L, Jia A, Xu GP (2004) Effects of estradiol on liver estrogen receptor-alpha and its mRNA expression in hepatic fibrosis in rats. World J Gastroenterol 10:250\u2013254","journal-title":"World J Gastroenterol"},{"key":"1577_CR61","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1021\/ac070494j","volume":"79","author":"X Xu","year":"2007","unstructured":"Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG (2007) Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 79:7813\u20137821","journal-title":"Anal Chem"},{"key":"1577_CR62","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1038\/ncomms8158","volume":"6","author":"J Xue","year":"2015","unstructured":"Xue J, Sharma V, Hsieh MH, Chawla A, Murali R, Pandol SJ, Habtezion A (2015) Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun 6:7158","journal-title":"Nat Commun"},{"key":"1577_CR63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molimm.2017.02.007","volume":"85","author":"C Yan","year":"2017","unstructured":"Yan C, Shen Y, Sun Q, Yuan D, Tang H, Gao H (2017) 2-Methoxyestradiol protects against IgG immune complex-induced acute lung injury by blocking NF-kappaB and CCAAT\/enhancer-binding protein beta activities. Mol Immunol 85:89\u201399","journal-title":"Mol Immunol"},{"key":"1577_CR64","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang CY, Yuan WG, He P, Lei JH, Wang CX (2016) Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol 22:10512\u201310522","journal-title":"World J Gastroenterol"},{"key":"1577_CR65","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1440-1827.2008.02274.x","volume":"58","author":"XY Zhao","year":"2008","unstructured":"Zhao XY, Wang BE, Li XM, Wang TL (2008) Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents. Pathol Int 58:580\u2013588","journal-title":"Pathol Int"},{"key":"1577_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jdermsci.2014.10.007","volume":"77","author":"L Zhu","year":"2015","unstructured":"Zhu L, Song Y, Li M (2015) 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation. J Dermatol Sci 77:63\u201370","journal-title":"J Dermatol Sci"},{"key":"1577_CR67","doi-asserted-by":"crossref","unstructured":"DOI: 10.7150\/ijbs.7.1273","DOI":"10.7150\/ijbs.7.1273"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-018-1577-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1577-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1577-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:06:34Z","timestamp":1775297194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-018-1577-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s00210-018-1577-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"3 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out in accordance with ethical standards in all aspects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}